Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Teikoku Pharma Announces Positive Results from Phase 2 Clinical Trial of TPU-006

americanpharmaceuticalreviewAugust 24, 2017

Tag: chronic pain , Teikoku Pharma , TPU-006

PharmaSources Customer Service